$153.39
0.38%
Nasdaq, Oct 31, 09:00 pm CET
ISIN
US0576652004
Symbol
BCPC

Balchem Corporation Stock price

$153.39
+3.33 2.22% 1M
-3.16 2.02% 6M
-9.61 5.89% YTD
-13.94 8.33% 1Y
+13.59 9.72% 3Y
+51.92 51.17% 5Y
+84.51 122.69% 10Y
+145.26 1,786.62% 20Y
Nasdaq, Closing price Fri, Oct 31 2025
-0.58 0.38%
ISIN
US0576652004
Symbol
BCPC
Sector
Industry

Key metrics

Basic
Market capitalization
$5.0b
Enterprise Value
$5.1b
Net debt
$90.7m
Cash
$65.1m
Shares outstanding
32.4m
Valuation (TTM | estimate)
P/E
33.6 | 29.5
P/S
4.9 | 4.8
EV/Sales
5.0 | 4.8
EV/FCF
31.3
P/B
3.8
Dividends
DPS
$0.87
Yield 1Y | 5Y
0.6% | 0.5%
Growth 1Y | 5Y
10.1% | 10.8%
Payout 1Y | 3Y
22.1% | 22.5%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$1.0b | $1.0b
EBITDA
$249.4m | $277.3m
EBIT
$204.5m | $210.5m
Net Income
$149.2m | $168.4m
Free Cash Flow
$161.6m
Growth (TTM | estimate)
Revenue
7.6% | 9.6%
EBITDA
11.3% | 19.5%
EBIT
18.2% | 14.4%
Net Income
22.8% | 31.1%
Free Cash Flow
-0.6%
Margin (TTM | estimate)
Gross
35.8%
EBITDA
24.6% | 26.5%
EBIT
20.2%
Net
14.7% | 16.1%
Free Cash Flow
15.9%
Financial Health
Equity Ratio
73.0%
Return on Equity
11.2%
ROCE
13.3%
ROIC
10.2%
Debt/Equity
0.1
More
EPS
$4.6
FCF per Share
$5.0
Short interest
1.9%
Employees
1k
Rev per Employee
$690.0k
Show more

Is Balchem Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Balchem Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Balchem Corporation forecast:

Buy
88%
Hold
13%

Financial data from Balchem Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,014 1,014
8% 8%
100%
- Direct Costs 650 650
5% 5%
64%
363 363
12% 12%
36%
- Selling and Administrative Expenses 140 140
3% 3%
14%
- Research and Development Expense 18 18
11% 11%
2%
249 249
11% 11%
25%
- Depreciation and Amortization 45 45
12% 12%
4%
EBIT (Operating Income) EBIT 204 204
18% 18%
20%
Net Profit 149 149
23% 23%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Balchem Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Balchem Corporation Stock News

Neutral
GlobeNewsWire
4 days ago
MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 55th Annual Global Industrial Conference on November 12, 2025.
Positive
Seeking Alpha
11 days ago
I raise my rating for Balchem from "Hold" to "Buy," following my assessment of its performance and prospects. BCPC's 3Q2025 financials exceeded expectations, thanks to the strong showing from its Human Nutrition and Specialty Products segments. I'm anticipating that Balchem can realize growth acceleration in the mid-term by capitalizing on emerging food trends, a new production plant, and promi...
Neutral
Seeking Alpha
12 days ago
Balchem Corporation (NASDAQ:BCPC ) Q3 2025 Earnings Call October 21, 2025 11:00 AM EDT Company Participants Carl Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Harris - CEO, President & Chairman Conference Call Participants Bob Labick - CJS Securities, Inc. Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Daniel Harriman - Sidoti & Company...
More Balchem Corporation News

Company Profile

marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in New Hampton, NY.

Head office United States
CEO Theodore Harris
Employees 1,379
Founded 1967
Website balchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today